← Evidence map

ArticleStatistics in biopharmaceutical research2022

A Composite Endpoint for Treatment Benefit According to Patient Preference.

Ying Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2022
2023
2024
2025
2026
this papertrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 37981982